Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ivarmacitinib (SHR0302)
i
Other names:
SHR0302, SHR 0302, SHR-0302
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Arcutis, Jiangsu Hengrui Pharma
Drug class:
JAK1 inhibitor, STAT3 inhibitor
Related drugs:
‹
ruxolitinib (73)
AZD1480 (5)
momelotinib (2)
DZD4205 (1)
INCB039110 (1)
tofacitinib (1)
INCB052793 (0)
BBI608 (4)
BP1003 (2)
NT-157 (2)
TTI-101 oral (2)
JSI-124 (2)
EC-70124 (1)
INB03 (1)
YHO-1701 (1)
niclosamide (1)
stattic (1)
CM-728 (0)
DUET-101 (0)
DUET-201 (0)
GLG-302 (0)
HJC0152 (0)
NT219 (0)
OPB-111077 (0)
STAT3 inhibitor (0)
sulforafan alfadex (0)
WP1066 (0)
SK&F106615 (0)
iMX-110 (0)
AZD9150 (0)
ACT001 (0)
BS-HH-002.SA (0)
VT-11CR (0)
ruxolitinib (73)
AZD1480 (5)
momelotinib (2)
DZD4205 (1)
INCB039110 (1)
tofacitinib (1)
INCB052793 (0)
BBI608 (4)
BP1003 (2)
NT-157 (2)
TTI-101 oral (2)
JSI-124 (2)
EC-70124 (1)
INB03 (1)
YHO-1701 (1)
niclosamide (1)
stattic (1)
CM-728 (0)
DUET-101 (0)
DUET-201 (0)
GLG-302 (0)
HJC0152 (0)
NT219 (0)
OPB-111077 (0)
STAT3 inhibitor (0)
sulforafan alfadex (0)
WP1066 (0)
SK&F106615 (0)
iMX-110 (0)
AZD9150 (0)
ACT001 (0)
BS-HH-002.SA (0)
VT-11CR (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login